Cardiac prosthetic devices find wide application in treatment of various heart conditions such as cardiomyopathy, valvular heart disease, and congenital heart disease. These devices are implanted surgically to replace damaged or diseased parts of the heart or to support the functioning of the heart. The key types of cardiac prosthetic devices available in the market include heart valves, ventricular assist devices, and implantable cardioverter defibrillators.
Cardiac Prosthetic Devices Market is estimated to be valued at USD 8.96 Bn in 2025 and is expected to reach USD 16.7 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 9.3% from 2025 to 2032.
Heart valves help in regulating the blood flow and pressure within the heart. They are replaced surgically in patients with conditions affecting the heart valves such as stenosis or regurgitation. Ventricular assist devices are mechanical pumps that are implanted in patients with heart failure to support the pumping function of the failing heart. Implantable cardioverter defibrillators continuously monitor the patient’s heartbeat and deliver electrical pulses or shocks to restore normal heart rhythm in case of irregular heartbeats. The increasing prevalence of cardiovascular diseases worldwide is the major factor driving the demand for cardiac prosthetic devices for treatment and management of various heart conditions.
Key Takeaways
Key players operating in the Cardiac Prosthetic Devices are Abbott., Artivion, Inc., Medtronic, Boston Scientific Corporation, Edwards Lifesciences Corporation., Siemens Healthcare Private Limited, LivaNova PLC (sorin group), Asahi Kasei Corporation., OSYPKA MEDICAL, Lepu Medical, MicroPort Scientific Corporation., Vitatron, Koninklijke Philips N.V., Progetti srl, and Shree Pacetronix Ltd.
The Cardiac Prosthetic Devices Market Opportunities growing with coupled with the rapidly aging global population is fueling the demand for cardiac prosthetic devices. In addition, technological advancements in terms of miniaturization and improved outcomes have increased the adoption of such devices for treatment of heart conditions.
Growing demand: The increasing number of patients suffering from cardiac diseases worldwide is a key factor driving the demand for cardiac prosthetic devices. Cardiovascular diseases pose a significant burden and remain the leading cause of death globally. The growing geriatric population also contributes to the rising prevalence of cardiac conditions requiring surgical treatment using such prosthetic devices.
Technological advancements: Ongoing research and development in the field of prosthetic heart valves, implantable cardiac devices, and ventricular assist devices have led to development of more effective and durable products. Miniaturization of implantable cardiac devices has improved outcomes. Advances in tissue engineering have enabled development of next-generation prosthetic heart valves with properties similar to natural heart valves.
Market trends: Some of the major trends in the cardiac prosthetic devices market include growing demand for minimally invasive valve replacement surgeries and tissue engineering advances to develop biomimetic heart valves. In addition, the clinical pipeline includes trials evaluating novel left ventricular assist devices and prosthetic mitral valves using transcatheter approaches.
Market Opportunities: Key growth opportunities in the cardiac prosthetic devices market revolve around developing innovative products addressing unmet needs in cardiac surgery. This includes developing next-generation tissue-engineered heart valves for pediatric patients and prosthetic valves compatible with magnetic resonance imaging. There is also scope for minimally invasive transcatheter options for mitral valve repair/replacement and development of fully implantable left ventricular assist devices.
Impact of COVID-19 on Cardiac Prosthetic Devices Market Growth
The COVID-19 pandemic severely impacted the cardiac prosthetic devices market initially. Non-essential procedures like elective surgeries using cardiac prosthetic devices were postponed during the peak of the pandemic to focus on handling critical COVID-19 cases. This led to a steep decline in demand and revenue for device manufacturers in 2020. However, as the pandemic is being brought under control through vaccination drives globally, the deferred procedures are being performed now. This is fueling a rebound in demand in 2021. However, supply chain disruptions caused by lockdowns delayed manufacturing and deliveries of devices. Going forward, companies are focusing on stockpiling critical components and diversifying supplier base to minimize future disruptions.
Geographically, North America dominates the market currently in terms of value due to advanced healthcare facilities and high adoption rates of new technologies. The US particularly accounts for the largest share owing to presence of major players and rising prevalence of cardiovascular diseases. However, Asia Pacific is expected to grow at the fastest pace during the forecast period. This is attributed to growing medical tourism, increasing healthcare spending, large patient pools and rising awareness about advanced treatment options in countries like China, India and Japan.
Geographical Regions with Highest Market Concentration
When it comes to geographical concentration in terms of value, currently North America leads the cardiac prosthetic devices market globally. The region accounts for over 35% of the total market revenue. Within North America, the US is the major revenue generator with a share of around 80%. This is because the US healthcare system has high per capita spending on healthcare and early adoption rates of advanced devices. There is well-established reimbursement system which encourages use of expensive technologies. Moreover, presence of leading global players and strong R&D also contributes to market dominance of the US. However, Asia Pacific is expected to witness fastest gains given growing economies, healthcare reforms and rising medical tourism in the region.
Fastest Growing Region for Cardiac Prosthetic Devices Market
Asia Pacific region is poised to be the fastest growing market for cardiac prosthetic devices globally during the forecast period. This is owed to factors like rising healthcare expenditure, growing Medical tourism industry and increasing focus of leading global players to tap opportunities in emerging countries. China and India specifically will drive the market due to huge patient population suffering from cardiovascular diseases along with growing affordability and awareness. Governments are also implementing various healthcare initiatives to boost innovation and improve access to advanced treatments. Overall increasing investments towards strengthening healthcare infrastructure, favorable reimbursements and expanding pool of patients are some of the key factors propelling the cardiac prosthetic devices market in the Asia Pacific region.
Get More Insights - Cardiac Prosthetic Devices Market
Get This Report in Japanese Language - 心臓人工器官市場
Get This Report in Korean Language -심장 보철 장치 시장
About Author:
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)
copyright src="chrome-extension://fpjppnhnpnknbenelmbnidjbolhandnf/content_script_web_accessible/ecp_regular.js" type="text/javascript">